Results 11 to 20 of about 25,001,430 (174)

Unicentric Castleman′s disease in the orbit: A case report

open access: yesIndian Journal of Ophthalmology, 2015
A 53-year-old man presented with a palpable mass on the left lower eyelid and occasional diplopia. Under suspicion of orbital lymphoma, an excisional biopsy was performed, and histopathology revealed Castleman′s disease.
Dongwan Kang   +3 more
doaj   +2 more sources

Castleman′s disease: Hyaline vascular type

open access: yesMedical Journal of Dr. D.Y. Patil University, 2014
Castleman′s disease is a rare disease of lymph node with two identified forms, the hyaline vascular type and plasma cell type. It presents as localized or systemic lymphadenopathy or even as extranodal mass and may give rise to several differential ...
Srikanth Shastry, Anandam Gadda
doaj   +2 more sources

Retinal vein occlusion during flare of multicentric Castleman's disease

open access: yesClinical Ophthalmology, 2013
Igor Kozak,1,2 Erin G Reid31King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia; 2University of California San Diego, Jacobs Retina Center at the Shiley Eye Center, La Jolla, CA, USA; 3University of California San Diego, Moores Cancer ...
Kozak I, Reid EG
doaj   +1 more source

A rare association of Castleman′s disease and nephrotic syndrome

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2011
Castleman′s Disease (CD) is an uncommon and poorly understood disorder of lymph node hyperplasia of unknown etiology. This entity belongs to the atypical lymphoproliferative disorders, a heterogeneous group of diseases characterized by a hyperplastic ...
I Tazi   +3 more
doaj   +1 more source

Castleman’s disease in the HIV-endemic setting

open access: yesCancer Management and Research, 2018
Esam-Rajab Mahroug,1 Candice Sher-Locketz,1 Minodora-Silvia Desmirean,2,3 Emmanuel-Akinola Abayomi,1,4 Ciprian Tomuleasa,3,5,6 Ravnit Grewal1,7 1Division of Haematology, Department of Pathology, University of Stellenbosch, Tygerberg Academic Hospital ...
Mahroug E   +5 more
doaj   +1 more source

An unusual unifocal presentation of Castleman’s disease in a young woman with a detailed description of sonographic findings to reduce diagnostic uncertainty: a case report [PDF]

open access: yes, 2013
Background: Castleman’s disease is a rare lymphoproliferative disorder. It typically presents as mediastinal masses and causes a wide range of clinical symptoms.
Zerrin Maden   +3 more
core   +1 more source

Retroperitoneal pararenal castleman’s disease: a case report

open access: yesJournal of Pathology of Nepal, 2013
Castleman’s diseas is a rare lymphoproliferative disorder of unknown etiology. We report a 28 years old woman with solitary Castleman’s disease in the left pararenal space. This case was diagnosed preoperatively as renal cell carcinoma.
S Shrestha   +3 more
doaj   +1 more source

Lenalidomideas a Second-line Therapy Achieves Long-term Remission in Elderly Patients with Relapsed/Refractory Multicentric Castleman's Disease:a Report of Two Cases and Literature Review [PDF]

open access: yesZhongguo quanke yixue, 2022
No standard therapy is recommended for elderly multicentric Castleman's disease (MCD) patients who failed to the first-line treatment or relapsed. Lenalidomide has been reported to be effective for relapsed/refractory MCD in foreign countries, but ...
TANG Yangming, SHI Renzhou, LAN Mei, LI Xuejun, WEN Zonghua, LU Xiaochen
doaj   +1 more source

Doppler findings In castleman disease - A rare case

open access: yesIndian Journal of Radiology and Imaging, 2006
Castleman′s disease is a rare, benign disease of unknown cause that induces reactive lymph node hyperplasia. It has two histologic subtypes: hyaline vascular and plasma cellular. A definitive diagnosis necessitates tissue biopsy.
S Raniga   +4 more
doaj   +1 more source

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies [PDF]

open access: yes, 2012
BACKGROUND: Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6 receptor (IL6R) signalling propagates downstream inflammation cascades.
Thomas, GN   +492 more
core   +1 more source

Home - About - Disclaimer - Privacy